• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Protection of Spermatogenetic damage induced by anti-cancer drug using LH-RH agonist.

Research Project

Project/Area Number 06671568
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionUniversity of Tsukuba

Principal Investigator

TAKESHIMA Hitoshi  Inst.of Clinic.Med., University of Tsukuba Assistant prof., 臨床医学系, 講師 (00197287)

Project Period (FY) 1994 – 1996
KeywordsSpermatogenesis / Spermatogenetic impairment / Anti-cancer drug / Doxorubicin / LH-RH agonist / Leuprorelin / Johnsen's score / Image cytometry
Research Abstract

INTRODUCTION AND OBJECTIVES : Spermatogenetic disorder in male patients after successful anticancer chemotherapy is one of important issues. Endocrinological suppression of germ cell division could protect spermatogenesis from anticancer drugs. In this study, LH-RH agonist (Leuprorelin) were used and evaluated its protective effect on spermatogenetic damage induced doxorubicin.
METHODS : SD strain malerats were divided into four groups. 1) control group, 2) LH-RH agonist (subcutaneous injections, total dose 9mg/kg) administered group, 3) doxorubicin (intraperitoneal injections, total dose 7.5mg/kg) administered group and 4) LH-RH agonist (subcutaneous injections, total dose 9mg/kg) and doxorubicin (intraperitoneal injections, total dose 7.5mg/kg)administered group. Evaluation was made by measuring body and testicular weights, counting the Johnsen's score, and DNA image analysis : DNA content measurement (%1C,%2C,%4C) by image cytometry.
RESULTS : In the group administtered adriamycin, the testicular weigth was 1.5<plus-minus>0.2mg, the Johnsen's score was 4.4<plus-minus>1.2, and image analysis revealed %1C : 33.8<plus-minus>9.2, %2C : 43.9<plus-minus>16.3 and %4C : 5.0<plus-minus>4.4 respectively. In both LH-RH agonist and adriamycin administered group, the testicular weight was 1.3<plus-minus>0.2mg, the Johnsen's score was 5.9<plus-minus>1.6, and image analysis disclosed %1C : 46.9<plus-minus>15.0, %2C : 28.4<plus-minus>13.3 and %4C : 8.8<plus-min
CONCLUSIONS : Significant prophylactic effect was demonstrated on Johnson's score (p<0.05) and by image analysis ; %1C (p<0.005), %2C (p<0.005) and %4C (p<0.05). Based on these results, it is concluded that LH-RH agonist could protect spermatogenesis from the damage induced by doxorubicin.

  • Research Products

    (2 results)

All Other

All Publications (2 results)

  • [Publications] 真鍋文雄 他: "Protecting Spermatogenesis from Damage Induced by Doxorubicin Using the Luteinizing Hormone-Releasing Hormone Agonist Leuprorelin -An Image Analysis Study of a Rat Experimental Model-" Cancer. 79. 1014-1021 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Manabe, Fumio et al.: "Protecting Spermatogenesis from Damage Induced by Doxorubicin Using the Luteinizing Hormone-Releasing Hormone Agonist Leuprorelin -An Image Analysis Study of a Rat Experimental Model-" Cancer. 79. 1014-1021 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi